0001209191-11-041504.txt : 20110729 0001209191-11-041504.hdr.sgml : 20110729 20110729094219 ACCESSION NUMBER: 0001209191-11-041504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110727 FILED AS OF DATE: 20110729 DATE AS OF CHANGE: 20110729 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIVINGSTON RANDALL S CENTRAL INDEX KEY: 0001235118 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 11995659 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-07-27 0 0001131324 GENOMIC HEALTH INC GHDX 0001235118 LIVINGSTON RANDALL S STANFORD UNIVERSITY BLDG 60, MAIN QUADRANGLE STANFORD CA 94305 1 0 0 0 Common Stock 2011-07-27 4 M 0 2000 1.3266 A 8149 D Common Stock 2011-07-27 4 S 0 2000 26.4535 D 6149 D Stock Option (right to buy) 1.3266 2011-07-27 4 M 0 2000 0.00 D 2014-10-06 Common Stock 2000 13346 D This sale of common stock was effected persuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 18, 2011. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $26.19 to $26.7805. The option became exercisable as to 25% of the shares on October 6, 2005,and became exercisable as to 1/48th of the shares each full month thereafter. Dean L. Schorno, Attorney-in-fact 2011-07-29